Evidence map›Paper›PMID 27101016›Full record

ReviewCurrent hematologic malignancy reports2016

Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Meenal Kheterpal, Neha Mehta-Shah, Pooja Virmani, Patricia L Myskowski, Alison Moskowitz, Steven M Horwitz

Open access · greenAbstract readReview
In one paragraph

Review in Current hematologic malignancy reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Next-generation sequencing in dermatology.Frontiers in medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Meenal KheterpalDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Neha Mehta-ShahDepartment of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pooja VirmaniDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Patricia L MyskowskiDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alison MoskowitzDepartment of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Steven M HorwitzDepartment of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. horwitzs@mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Cutaneous lymphomas (CL) are a heterogeneous group of neoplasms characterized with clinical and histopathological variation, as well as overlap with benign dermatoses. Diagnosis and treatment of CLs is challenging and often requires a multidisciplinary approach. However, prognostic knowledge of these conditions and awareness of treatment options can help optimize appropriate use of available regimens, thereby improving care for patients. Here, we review the most recent literature and outline treatment themes for managing patients with cutaneous B-cell and T-cell lymphomas other than mycosis fungoides.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsHumansLymphoma, B-CellLymphoma, T-CellMycosis FungoidesPractice Guidelines as TopicRecurrenceSkin NeoplasmsTranslocation, GeneticCutaneous T-cell lymphomaMultidisciplinary approachNon-mycosis fungoidesPrimary cutaneous B-cell lymphomaSkin-directed treatmentSystemic treatment

Identifiers

PMID27101016
PMCPMC5611851
OpenAlexW2338413914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.